×

LMNB1/CDKN1A signaling regulates the cell cycle and promotes hepatocellular carcinoma progression.

Current Cancer Drug Targets Gao, Dute, et al.
2025 IF: 3.500 货号:KTA2031

αKG-induced oxidative stress and mTOR inhibition as a therapeutic strategy for liver cancer.

Medical Oncology Choi, Sung Kyung, Myoung Jun Kim, and Jueng Soo You.
2025 IF: 3.500 货号:BMP1001
400电话
在线咨询
技术支持
公众号
公众号
返回顶部